DIABETES
SOLUTION: REVISED AND UPDATED
By Richard K. Bernstein, M.D.
512 pages packed with new information on Diet, Exercise,
Curbing Carbohydrate cravings, new insulin regimens, monitoring blood
sugars, helping physicans and patients to regulate blood sugars plus much,
much more. “RUN DON’T WALK TO GET THIS
BOOK” -- Michael R. Eades, M.D. Author of Protein Power.
More...>
Tools
For Your Practice
New
WebSite for the NIDDK clearinghouse. The
site includes links to a new online publications catalog, so you can
order NIDDK materials 24 hours a day. You can order single free copies
of most materials or place a bulk order. A lot of great information
and materials for your patients. Check it out at diabetes.niddk.nih.gov
Ethanol
overdosage is the leading cause of death due to low blood sugar in the
United States. Dr. Evan Rosen, M.D., Ph.D discusses why
in Diabetes and Drinking.
Dr. Thomas Burke Ph.D
Summary
of Prospective Peripheral Neuropathy Studies of 220 Limbs.
With only 2 weeks to go until AADE we want to remind you
that we will be in at Booth #1333, between
Roche, Aventis and Takeda. Please stop by to see our special
presentations. Make sure you check out the Diabetes In Control
Steps Contest, CLICK
HERE TO SEE EVERYTHING WE HAVE FOR YOU
Diabetes Diet War. Dr. Richard Bernstein
and others were recently interviewed for U.S. News
& World Report on the current controversy of
low carb diets. Check
it out Please click
here to give us your opinion.
Timothy S. Hollingshead, DPM, President,
The Hollingshead Group brings us information on how to reduce
malpractice in his feature Communication: One
of the Keys to Risk Management
This week’s overview: Item#3: Long-Term
Efficacy Of Metformin In Type 2 Diabetes? Item:#10: New Definition
of Metabolic Syndrome Improves Risk Prediction With Diabetes
and CHD Item #12: Daily Vioxx
® Can Cause Spike in Blood Pressure for Those with Diabetes
Check out this weeks “Test Your Knowledge”
question. Click Here
Dave
Joffe, Editor-in-Chief, CDE, FACA
Consider
making Diabetes in Control Your home page.
NewsFlash: NEW DRUG TARGETS BOTH THE LIVER AND THE PANCREAS
Researchers said on Thursday they had found a new class of
drugs that might attack diabetes on more than one front --
and that could be taken as a pill. See
Item#5FDA ADVISORY COMMITTEE UNANIMOUSLY
RECOMMENDS ASTRAZENECA’S CRESTOR FOR APPROVAL
1. Gum Disease Raises Death Risk in Diabetics Click Here
2. Postnatal Fasting Plasma Glucose Determines Need for
Oral Glucose Tolerance Test Click Here
3. Long-Term Efficacy Of Metformin In Type 2 Diabetes? Click Here
4. DECODE Study De-Emphasises Importance of Fasting Glucose* Click Here
5. New Drug Targets Liver and Pancreas* Click Here
6. Gestational Diabetes Raises Risk of Metabolic Syndrome Click Here
7. Carbohydrates Can Induce Memory Impairment in Type 2
Diabetes* Click Here
8. Women With Impaired Glucose Tolerance Increase Their
Risk of Morbidity for Their Infants Click Here
9 New Definition of Metabolic Syndrome Improves Risk Prediction
With Diabetes and CHD Click Here
10. Statin Use Does Not Reduce Fracture Risk in Postmenopausal
Women Click Here
11. RAS Blockade Improves Insulin Sensitivity in Essential
Hypertensives Click Here
12. Daily Vioxx ® Can Cause Spike in Blood Pressure
for Those with Diabetes Click Here
13. Troponin and CRP Levels Predict Mortality in End-Stage
Renal Disease Patients Click Here
14. Roche Gets FDA Warning on Disetronic Medical Systems
Insulin Pump Plant Click Here
15. Growing New Teeth, Could Beta Cells Be Next? Click Here
Product
Update A1cNow
is Now Over the Counter-No Prescription Needed!
Let
your Patients Check Their Own A1c Levels. It will motivate
to better control. www.a1cnow.net
QUOTE OF THE WEEK
"Every
generalization is dangerous, especially this one."
Mark Twain
News
Flash
Prescription
Drug Plan Faces Tests Insurers' Participation Uncertain, Experts
Say
Congress's dramatic pre-dawn votes
on Friday to add prescription drug benefits to Medicare
were a political milestone, authorizing the biggest
expansion of the program since its birth. But health
policy analysts say that, even if the House and the
Senate are able to resolve differences between their
bills, it is far from certain the plan would work.
The drug coverage envisioned by Congress and the White
House relies on two kinds of private insurance methods:
separate policies solely for drugs, something that
does not currently exist, and preferred-provider networks,
a health plan that is common among younger people
but includes few Medicare patients. Read
More...>
Carbohydrates Can Induce Memory Impairment in Type 2 Diabetes* Click
Here
Gum Disease Raises Death Risk in Diabetics Click
Here
Dr
Richard K. Bernstein
Diet
Wars
Dr. Richard Bernstein and others were recently interviewed
for U.S. News & World Report on the current controversy of low carb
diets. Check
it out
Information on Dr. Richard Bernstein's New Book
New
CE Program
CE:
Insulin Delivery:
What Are the Options?
The goal of this educational activity is to address the
important role of insulin delivery systems in helping patients meet their
individual therapeutic goals.
Click for Free CE
Summary
of Chromium
“Chromium
in Health and Disease”
A Council for the Advancement of Diabetes
Research and Education (CADRE) Chromium Summit, held April 2003 in Boston.
The Summit was co-chaired by William T. Cefalu, MD, University
of Vermont and Frank Hu, MD, PhD, Harvard School of Public Health.
Click Here
Evan
D. Rosen, M.D., Ph.D 
Brings
us information on how to reduce malpractice in his feature
Communication: 
DIABETES
SOLUTION: REVISED AND UPDATED 
New
WebSite for the NIDDK clearinghouse. The
site includes links to a new online publications catalog, so you can
order NIDDK materials 24 hours a day. You can order single free copies
of most materials or place a bulk order. A lot of great information
and materials for your patients. Check it out at 
Brings
use part 5 of his series 
Melissa
Diane Smith
Only 48% of our patients are screened for nephropathy. Evan
David Rosen, M.D., Ph.D. brings us the latest information
why we should try for 100%. 
A1cNow
is Now Over the Counter-No Prescription Needed!
Congress's dramatic pre-dawn votes
on Friday to add prescription drug benefits to Medicare
were a political milestone, authorizing the biggest
expansion of the program since its birth. But health
policy analysts say that, even if the House and the
Senate are able to resolve differences between their
bills, it is far from certain the plan would work.
DECODE
Study De-Emphasises Importance of Fasting Glucose* 
The goal of this educational activity is to address the
important role of insulin delivery systems in helping patients meet their
individual therapeutic goals. 
Paul
Chous, 
Dr.
Eric Freedland's
